Response to Letter to the Editor on “Impact of the Surgical Approach for Neoadjuvantly Treated Gastroesophageal Junction Type II Tumors: A Multinational, High-Volume Center Retrospective Cohort Analysis”
Saved in:
Main Authors: | Naita M. Wirsik, MD, Thomas Schmidt, MD, PhD, Christiane J. Bruns, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health
2024-09-01
|
Series: | Annals of Surgery Open |
Online Access: | http://journals.lww.com/10.1097/AS9.0000000000000479 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comment on “Impact of the Surgical Approach for Neoadjuvantly Treated Gastroesophageal Junction Type II Tumors: A Multinational, High-Volume Center Retrospective Cohort Analysis”
by: Arnar B. Ingason, MD, PhD, et al.
Published: (2024-06-01) -
Efficacy of Neoadjuvant Chemotherapy DOX and XELOX Regimens for Patients with Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
by: Yuan Tian, et al.
Published: (2021-01-01) -
Neoadjuvant Chemoradiotherapy Upregulates the Immunogenicity of Cold to Hot Tumors in Esophageal Cancer Patients
by: Yushi Nagaki, MD, PhD, et al.
Published: (2024-03-01) -
Surgical Outcomes Following Neoadjuvant Treatment for Locally Advanced and Borderline Resectable Pancreatic Ductal Adenocarcinoma
by: Kai Tai Derek Yeung, PhD, FRCS, et al.
Published: (2024-09-01) -
Letter to the Editor
by: Ishir Narayan
Published: (2023-04-01)